loadpatents
Patent applications and USPTO patent grants for Gu; Wenxin.The latest application filed is for "substituted quinoxaline dna-pk inhibitors".
Patent | Date |
---|---|
Substituted Quinoxaline Dna-pk Inhibitors App 20210236505 - Maxwell; John Patrick ;   et al. | 2021-08-05 |
Pteridinone compounds and uses thereof Grant 11,059,826 - Lauffer , et al. July 13, 2 | 2021-07-13 |
Substituted quinoxaline DNA-PK inhibitors Grant 10,973,830 - Maxwell , et al. April 13, 2 | 2021-04-13 |
Dna-pk Inhibitors App 20210069203 - Maxwell; John Patrick ;   et al. | 2021-03-11 |
Inhibitors Of Influenza Viruses Replication App 20210040092 - Charifson; Paul S. ;   et al. | 2021-02-11 |
Inhibitors of influenza viruses replication Grant 10,875,855 - Charifson , et al. December 29, 2 | 2020-12-29 |
Inhibitors of influenza viruses replication Grant 10,874,673 - Charifson , et al. December 29, 2 | 2020-12-29 |
DNA-PK inhibitors Grant 10,786,512 - Maxwell , et al. September 29, 2 | 2020-09-29 |
Triazoles for the treatment of demyelinating dieases Grant 10,766,869 - Davies , et al. Sep | 2020-09-08 |
Pteridinone Compounds And Uses Thereof App 20190322673 - Lauffer; David J. ;   et al. | 2019-10-24 |
Dna-pk Inhibitors App 20190290654 - Maxwell; John Patrick ;   et al. | 2019-09-26 |
Dna-pk Inhibitors App 20190255062 - Maxwell; John Patrick ;   et al. | 2019-08-22 |
Triazoles For The Treatment Of Demyelinating Diseases App 20190185436 - Davies; Robert J. ;   et al. | 2019-06-20 |
Inhibitors Of Influenza Viruses Replication App 20190151314 - Charifson; Paul S. ;   et al. | 2019-05-23 |
DNA-PK inhibitors Grant 10,258,627 - Maxwell , et al. | 2019-04-16 |
Triazoles for the treatment of Demyelinating Diseases Grant 10,118,904 - Davies , et al. November 6, 2 | 2018-11-06 |
Dna-pk Inhibitors App 20180311254 - Maxwell; John Patrick ;   et al. | 2018-11-01 |
1,3-substituted Pyrazole Compounds Useful For Reduction Of Very Long Chain Fatty Acid Levels App 20180251431 - Charifson; Paul S. ;   et al. | 2018-09-06 |
Inhibitors of influenza viruses replication Grant 10,039,762 - Charifson , et al. August 7, 2 | 2018-08-07 |
Dna-pk Inhibitors App 20180161336 - Maxwell; John Patrick ;   et al. | 2018-06-14 |
Inhibitors Of Influenza Viruses Replication App 20180155342 - Charifson; Paul S. ;   et al. | 2018-06-07 |
Substituted benzooxadiazole DNA-PK inhibitors Grant 9,987,284 - Maxwell , et al. June 5, 2 | 2018-06-05 |
Inhibitors Of Influenza Viruses Replication App 20180078553 - Charifson; Paul S. ;   et al. | 2018-03-22 |
Inhibitors of influenza viruses replication Grant 9,908,878 - Charifson , et al. March 6, 2 | 2018-03-06 |
Inhibitors of influenza viruses replication Grant 9,808,459 - Charifson , et al. November 7, 2 | 2017-11-07 |
Inhibitors Of Influenza Viruses Replication App 20170100400 - Charifson; Paul S. ;   et al. | 2017-04-13 |
Inhibitors of influenza viruses replication Grant 9,518,056 - Charifson , et al. December 13, 2 | 2016-12-13 |
Inhibitors Of Influenza Viruses Replication App 20160355512 - Charifson; Paul S. ;   et al. | 2016-12-08 |
Triazoles For The Treatment Of Demyelinating Diseases App 20160355488 - Davies; Robert J. ;   et al. | 2016-12-08 |
Dna-pk Inhibitors App 20160354381 - Maxwell; John Patrick ;   et al. | 2016-12-08 |
Dna-pk Inhibitors App 20160340341 - Maxwell; John Patrick ;   et al. | 2016-11-24 |
Inhibitors of influenza viruses replication Grant 9,394,302 - Charifson , et al. July 19, 2 | 2016-07-19 |
DNA-PK inhibitors Grant 9,359,380 - Maxwell , et al. June 7, 2 | 2016-06-07 |
Inhibitors Of Influenza Viruses Replication App 20160152614 - Charifson; Paul S. ;   et al. | 2016-06-02 |
Inhibitors of influenza viruses replication Grant 9,345,708 - Charifson , et al. May 24, 2 | 2016-05-24 |
Substituted quinoxaline DNA-PK inhibitors Grant 9,340,557 - Maxwell , et al. May 17, 2 | 2016-05-17 |
Inhibitors Of Influenza Viruses Replication App 20150191468 - Charifson; Paul S. ;   et al. | 2015-07-09 |
Inhibitors of influenza viruses replication Grant 9,051,319 - Charifson , et al. June 9, 2 | 2015-06-09 |
Inhibitors Of Influenza Viruses Replication App 20140296201 - Charifson; Paul S. ;   et al. | 2014-10-02 |
Inhibitors of influenza viruses replication Grant 8,829,007 - Charifson , et al. September 9, 2 | 2014-09-09 |
Inhibitors Of Influenza Viruses Replication App 20140142119 - Charifson; Paul S. ;   et al. | 2014-05-22 |
Inhibitors Of Influenza Viruses Replication App 20140094473 - Charifson; Paul S. ;   et al. | 2014-04-03 |
Inhibitors Of Influenza Viruses Replication App 20130345218 - Charifson; Paul S. ;   et al. | 2013-12-26 |
Cyclic peptide antitumor agents Grant 8,492,345 - Silverman , et al. July 23, 2 | 2013-07-23 |
Inhibitors Of Influenza Viruses Replication App 20120171245 - Charifson; Paul S. ;   et al. | 2012-07-05 |
Cyclic Peptide Antitumor Agents App 20120122799 - Silverman; Richard B. ;   et al. | 2012-05-17 |
Cyclic peptide antitumor agents Grant 8,058,244 - Silverman , et al. November 15, 2 | 2011-11-15 |
Cyclic Peptide Antitumor Agents App 20100204088 - Silverman; Richard B. ;   et al. | 2010-08-12 |
Cyclic peptide antitumor agents Grant 7,709,443 - Silverman , et al. May 4, 2 | 2010-05-04 |
Cyclic peptide antitumor agents App 20050159346 - Silverman, Richard B. ;   et al. | 2005-07-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.